首页    期刊浏览 2025年04月21日 星期一
登录注册

文章基本信息

  • 标题:Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
  • 本地全文:下载
  • 作者:Claudia Biguetti ; Mauro Toledo Marrelli ; Marco Brotto
  • 期刊名称:Revista de Saúde Pública
  • 印刷版ISSN:0034-8910
  • 出版年度:2020
  • 卷号:54
  • DOI:10.11606/s1518-8787.2020054002631
  • 语种:English
  • 出版社:Universidade de São Paulo
  • 摘要:Chloroquine (CQ) and its analog hydroxychloroquine (HCQ) were recently included in several clinical trials as potential prophylactic and therapeutic options for SARS-COV-2 infection/covid-19. However, drug effectiveness in preventing, treating, or slowing the progression of the disease is still unknown. Despite some initial promising in vitro results, rigorous pre-clinical animal studies and randomized clinical trials have not been performed yet. On the other hand, while the potential effectiveness of CQ/HCQ is, at best, hypothetical, their side effects are factual and most worrisome, particularly when considering vulnerable groups of patients being treated with these drugs. in this comment, we briefly explain the possible mechanisms of action of CQ/HCQ for treating other diseases, possible actions against covid-19, and their potent side effects, in order to reinforce the necessity of evaluating the benefit-risk balance when widely prescribing these drugs for SARS-COV-2 infection/covid-19. We conclude by strongly recommending against their indiscriminate use.
国家哲学社会科学文献中心版权所有